Browse by UCL people
Group by: Type | Date
Number of items: 44.
Article
Astermark, Jan;
Buckner, Tyler W;
Frenzel, Laurent;
Hatswell, Anthony J;
You, Xiaojun;
Liu, Hai;
Goodman, Erin;
... Klamroth, Robert; + view all
(2023)
Matching-adjusted indirect comparison of bleeding outcomes in severe haemophilia A: Comparing valoctocogene roxaparvovec gene therapy, emicizumab prophylaxis, and FVIII replacement prophylaxis.
Haemophilia
10.1111/hae.14818.
(In press).
|
|
Bullement, Ash;
Podkonjak, Tanja;
Robinson, Mark J;
Benson, Eugene;
Selby, Ross;
Hatswell, Anthony J;
Shields, Gemma E;
(2020)
Real-world evidence use in assessments of cancer drugs by NICE.
International Journal of Technology Assessment in Health Care
, 36
(4)
pp. 388-394.
10.1017/S0266462320000434.
|
|
Bullement, Ash;
Taylor, Matthew;
McMordie, Sam Thomas;
Waters, Errol;
Hatswell, Anthony James;
(2019)
NICE, in Confidence: An Assessment of Redaction to Obscure Confidential Information in Single Technology Appraisals by the National Institute for Health and Care Excellence.
PharmacoEconomics
, 37
pp. 1383-1390.
10.1007/s40273-019-00818-0.
|
|
Bullement, A;
McMordie, ST;
Hatswell, AJ;
Li, N;
Wilson, K;
(2020)
Cost-Effectiveness Analysis of Recombinant Factor VIII Fc-Fusion Protein (rFVIIIFc) for the Treatment of Severe Hemophilia A in Italy Incorporating Real-World Dosing and Joint Health Data.
PharmacoEconomics Open
, 4
(1)
pp. 133-142.
10.1007/s41669-019-0158-8.
|
 |
|
Bullement, A;
Nathan, P;
Willis, A;
Amin, A;
Lilley, C;
Stapelkamp, C;
Hatswell, A;
... Bharmal, M; + view all
(2019)
Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma.
PharmacoEconomics - Open
, 3
pp. 377-390.
10.1007/s41669-018-0115-y.
|
|
|
Bullement, A;
Willis, A;
Amin, A;
Schlichting, M;
Hatswell, AJ;
Bharmal, M;
(2020)
Evaluation of survival extrapolation in immuno-oncology using multiple pre-planned data cuts: learnings to aid in model selection.
BMC Medical Research Methodology
, 20
(1)
, Article 103. 10.1186/s12874-020-00997-x.
|
|
|
Di Tanna, GL;
Porter, JK;
Lipton, RB;
Brennan, A;
Palmer, S;
Hatswell, AJ;
Sapra, S;
(2019)
Migraine day frequency in migraine prevention: longitudinal modelling approaches.
BMC Medical Research Methodology
, 19
, Article 20. 10.1186/s12874-019-0664-5.
|
|
|
Di Tanna, GL;
Porter, JK;
Lipton, RB;
Hatswell, AJ;
Sapra, S;
Villa, G;
(2019)
Longitudinal assessment of utilities in patients with migraine: an analysis of erenumab randomized controlled trials.
Health Qual Life Outcomes
, 17
(1)
, Article 171. 10.1186/s12955-019-1242-6.
|
|
|
Farmer, Caroline;
Bullement, Ash;
Packman, David;
Long, Linda;
Robinson, Sophie;
Nikram, Elham;
Hatswell, Anthony J;
... Crathorne, Louise; + view all
(2020)
Voretigene Neparvovec for Treating Inherited Retinal Dystrophies Caused by RPE65 Gene Mutations: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Appraisal.
PharmacoEconomics
, 38
pp. 1309-1318.
10.1007/s40273-020-00953-z.
|
|
Ghione, Paola;
Palomba, M Lia;
Ghesquieres, Hervé;
Bobillo, Sabela;
Patel, Anik R;
Nahas, Myrna;
Kanters, Steve;
... Gribben, John; + view all
(2022)
Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study.
Haematologica
10.3324/haematol.2022.281421.
(In press).
|
|
Ghione, Paola;
Palomba, M Lia;
Patel, Anik R;
Bobillo, Sabela;
Deighton, Kevin;
Jacobson, Caron A;
Nahas, Myrna;
... Gribben, John G; + view all
(2022)
Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma.
Blood
, 140
(8)
pp. 851-860.
10.1182/blood.2021014375.
|
|
Gregory, J;
Dyer, M;
Hoyle, C;
Mann, H;
Hatswell, AJ;
(2020)
The validation of published utility mapping algorithms: an example of EORTC QLQ-C30 and EQ-5D in non-small cell lung cancer.
Health Economics Review
, 10
(1)
, Article 10. 10.1186/s13561-020-00269-w.
|
|
|
Hatswell, Anthony;
(2022)
Smaller science company? Tailor your CV for a manager, not HR.
Nature
10.1038/d41586-022-00557-x.
|
|
Hatswell, Anthony J;
(2023)
Incorporating Prior Beliefs Into Meta-Analyses of Health-State Utility Values Using the Bayesian Power Prior.
Value in Health
, 26
(9)
pp. 1389-1397.
10.1016/j.jval.2023.04.012.
|
|
|
Hatswell, Anthony J;
Bullement, Ash;
Schlichting, Michael;
Bharmal, Murtuza;
(2020)
What is the Impact of the Analysis Method Used for Health State Utility Values on QALYs in Oncology? A Simulation Study Comparing Progression-Based and Time-to-Death Approaches.
Applied Health Economics and Health Policy
, 19
(3)
pp. 389-401.
10.1007/s40258-020-00620-6.
|
|
Hatswell, Anthony J;
Chaudhary, Mohammad A;
Monnickendam, Giles;
Moreno-Koehler, Alejandro;
Frampton, Katie;
Shaw, James W;
Penrod, John R;
(2023)
Modelling Health State Utilities as a Transformation of Time to Death in Patients with Non-Small Cell Lung Cancer.
PharmacoEconomics
, 42
pp. 109-116.
10.1007/s40273-023-01314-2.
|
 |
|
Hatswell, Anthony J;
Deighton, Kevin;
Snider, Julia Thornton;
Brookhart, M Alan;
Faghmous, Imi;
Patel, Anik R;
(2022)
Approaches to Selecting "Time Zero" in External Control Arms with Multiple Potential Entry Points: A Simulation Study of 8 Approaches.
Medical Decision Making
, 42
(7)
pp. 893-905.
10.1177/0272989X221096070.
|
|
Hatswell, Anthony J;
Pennington, Becky;
Pericleous, Louisa;
Rowen, Donna;
Lebmeier, Maximilian;
Lee, Dawn;
(2014)
Patient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death.
Health and Quality of Life Outcomes
, 12
, Article 140. 10.1186/s12955-014-0140-1.
|
|
|
Hatswell, A;
Freemantle, N;
Baio, G;
Lesaffre, E;
van Rosmalen, J;
(2020)
Summarising salient information on historical controls: A structured assessment of validity and comparability across studies.
Clinical Trials
10.1177/1740774520944855.
(In press).
|
|
|
Hatswell, AJ;
(2020)
Learnings for Health Economics from the Early Stages of the COVID-19 Pandemic.
PharmacoEconomics Open
, 4
(2)
pp. 203-205.
10.1007/s41669-020-00216-9.
|
|
|
Hatswell, AJ;
(2017)
How do we avoid disaster when exiting the European Medicines Agency? Making the most of Brexit in pharmaceutical regulation.
[Editorial comment].
ecancermedicalscience
, 11
, Article ed67. 10.3332/ecancer.2017.ed67.
|
|
|
Hatswell, AJ;
Baio, G;
Berlin, JA;
Irs, A;
Freemantle, N;
(2016)
Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999-2014.
BMJ Open
, 6
(6)
, Article e011666. 10.1136/bmjopen-2016-011666.
|
|
Hatswell, AJ;
Bullement, A;
Briggs, A;
Paulden, M;
Stevenson, MD;
(2018)
Probabilistic Sensitivity Analysis in Cost-Effectiveness Models: Determining Model Convergence in Cohort Models.
PharmacoEconomics
, 36
(12)
pp. 1421-1426.
10.1007/s40273-018-0697-3.
|
|
Hatswell, AJ;
Burns, D;
Baio, G;
Wadelin, F;
(2019)
Frequentist and Bayesian meta‐regression of health state utilities for multiple myeloma incorporating systematic review and analysis of individual patient data.
Health Economics
, 28
(5)
pp. 653-665.
10.1002/hec.3871.
|
|
Hatswell, AJ;
Chandler, F;
(2017)
Sharing is Caring: The Case for Company-Level Collaboration in Pharmacoeconomic Modelling.
[Letter].
Pharmacoeconomics
, 35
(8)
pp. 755-757.
10.1007/s40273-017-0516-2.
|
|
Hatswell, AJ;
Freemantle, N;
Baio, G;
(2020)
The Effects of Model Misspecification in Unanchored Matching-Adjusted Indirect Comparison (MAIC): Results of a Simulation Study.
Value in Health
, 23
(6)
pp. 751-759.
10.1016/j.jval.2020.02.008.
|
|
Hatswell, AJ;
Freemantle, N;
Baio, G;
(2016)
Economic Evaluations of Pharmaceuticals Granted a Marketing Authorisation Without the Results of Randomised Trials: A Systematic Review and Taxonomy.
PharmacoEconomics
, 35
(2)
pp. 163-176.
10.1007/s40273-016-0460-6.
|
|
Hatswell, AJ;
Porter, JK;
(2019)
Reducing Drug Wastage in Pharmaceuticals Dosed by Weight or Body Surface Areas by Optimising Vial Sizes.
Applied Health Economics and Health Policy
, 17
(3)
pp. 391-397.
10.1007/s40258-018-0444-0.
|
|
Hatswell, AJ;
Sullivan, WG;
(2019)
Creating historical controls using data from a previous line of treatment – Two non-standard approaches.
Statistical Methods in Medical Research
10.1177/0962280219826609.
(In press).
|
|
|
Hatswell, AJ;
Thompson, GJ;
Maroudas, PA;
Sofrygin, O;
Delea, TE;
(2017)
Estimating outcomes and cost effectiveness using a single-arm clinical trial: ofatumumab for double-refractory chronic lymphocytic leukemia.
Cost Effectiveness and Resource Allocation
, 15
, Article 8. 10.1186/s12962-017-0071-x.
|
|
|
Hatswell, AJ;
Vegter, S;
(2016)
Measuring quality of life in opioid-induced constipation: mapping EQ-5D-3 L and PAC-QOL.
Health Economics Review
, 6
, Article 14. 10.1186/s13561-016-0091-9.
|
|
|
Lee, DC;
Gladwell, D;
Hatswell, AJ;
Porter, J;
Brereton, N;
Tate, E;
Saunders, AL;
(2014)
A comparison of the cost-effectiveness of treatment of prolonged acute convulsive epileptic seizures in children across Europe.
Health Economics Review
, 4
, Article 6. 10.1186/s13561-014-0006-6.
|
|
|
Lipton, RB;
Brennan, A;
Palmer, S;
Hatswell, AJ;
Porter, JK;
Sapra, S;
Villa, G;
... Dodick, D; + view all
(2018)
Estimating, the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective.
Journal of Medical Economics
, 21
(7)
pp. 666-675.
10.1080/13696998.2018.1457533.
|
|
Marriott, ER;
Van Hazel, G;
Gibbs, P;
Hatswell, AJ;
(2017)
Mapping EORTC-QLQ-C30 to EQ-5D-3L in patients with colorectal cancer.
Journal of Medical Economics
, 20
(2)
pp. 193-199.
10.1080/13696998.2016.1241788.
|
|
Muszbek, N;
Kadambi, A;
Lanitis, T;
Hatswell, AJ;
Patel, D;
Wang, L;
Singer, JW;
(2016)
The Cost-effectiveness of Pixantrone for Third/Fourth-line Treatment of Aggressive Non-Hodgkin's Lymphoma.
Clinical Therapeutics
, 38
(3)
pp. 503-515.
10.1016/j.clinthera.2016.01.004.
|
|
Palomba, M Lia;
Ghione, Paola;
Patel, Anik R;
Nahas, Myrna;
Beygi, Sara;
Hatswell, Anthony J;
Kanters, Steve;
... Bobillo, Sabela; + view all
(2023)
A 24-month updated analysis of the comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma.
Expert Review of Anticancer Therapy
10.1080/14737140.2023.2171994.
(In press).
|
|
Pennington, Becky;
Eaton, Jack;
Hatswell, Anthony J;
Taylor, Helen;
(2022)
Carers' Health-Related Quality of Life in Global Health Technology Assessment: Guidance, Case Studies and Recommendations.
PharmacoEconomics
, 40
(9)
pp. 837-850.
10.1007/s40273-022-01164-4.
|
|
Pennington, B;
Marriott, E-R;
Lichtlen, P;
Akbar, A;
Hatswell, AJ;
(2018)
The Cost Effectiveness of Lubiprostone in Chronic Idiopathic Constipation.
PharmacoEconomics - Open
, 2
(3)
pp. 241-253.
10.1007/s41669-017-0065-9.
|
|
|
Sampson, Christopher James;
Arnold, Renee;
Bryan, Stirling;
Clarke, Philip;
Ekins, Sean;
Hatswell, Anthony;
Hawkins, Neil;
... Wrightson, Tim; + view all
(2019)
Transparency in Decision Modelling: What, Why, Who and How?
PharmacoEconomics
, 37
(11)
pp. 1355-1369.
10.1007/s40273-019-00819-z.
|
|
Sullivan, WG;
Hatswell, AJ;
(2021)
Letter re: 'Intrapatient comparisons of efficacy in a single-arm trial of entrectinib in tumour-agnostic indications'.
ESMO Open
, 6
(6)
, Article 100282. 10.1016/j.esmoop.2021.100282.
|
|
Tomazos, Ioannis;
Hatswell, Anthony J;
Cataland, Spero;
Chen, Peter;
Freemantle, Nick;
Lommele, Asa;
Deighton, Kevin;
... Rondeau, Eric; + view all
(2022)
Comparative efficacy of ravulizumab and eculizumab in the treatment of atypical hemolytic uremic syndrome: An indirect comparison using clinical trial data.
Clinical Nephrology
, 97
(5)
pp. 261-272.
10.5414/CN110516.
|
|
van der Nelson, HA;
Draycott, T;
Siassakos, D;
Yau, CW;
Hatswell, AJ;
(2017)
Carbetocin versus oxytocin for prevention of post-partum haemorrhage at caesarean section in the United Kingdom: An economic impact analysis.
Eur J Obstet Gynecol Reprod Biol
, 210
pp. 286-291.
10.1016/j.ejogrb.2017.01.004.
|
|
Yang, Mo;
Vioix, Helene;
Hook, Emma S;
Hatswell, Anthony J;
Batteson, Rachael L;
Gaumond, Bruce R;
O'Brate, Aurora;
... Paik, Paul K; + view all
(2023)
Health Utility Analysis of Tepotinib in Patients with Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping.
Value Health
10.1016/j.jval.2023.02.007.
(In press).
|
Thesis
|
Hatswell, Anthony James;
(2020)
A modelling framework for estimation of comparative effectiveness in pharmaceuticals using uncontrolled clinical trials.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
